Obesity: open trials in Denmark

• NCT06937086

  Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Aarhus Universitetshospital, Skejby, Aarhus · Rigshospitalet, Copenhagen · Herlev and Gentofte Hospital, Copenhagen · Aalborg Universitetshospital, Syd, Gistrup · Odense Universitetshospital, Odense · Vejle Sygehus, Vejle

  Registry updated 2026-11-04

• NCT06937099

  Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Aarhus Universitetshospital, Skejby, Aarhus · Herlev and Gentofte Hospital, Copenhagen · Rigshospitalet, Copenhagen · Aalborg Universitetshospital, Syd, Gistrup · Odense Universitetshospital, Odense · Vejle Sygehus, Vejle

  Registry updated 2026-11-04

• NCT07353931

  Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Sanos A/S, Gandrup · Sanos A/S, Herlev · Sanos A/S, Vejle

  Registry updated 2026-11-04

• NCT07854886

  Hypothalamic GLP-1 Response in Healthy Weight and Obesity

  Trial Treatment · University of Copenhagen

  University of Copenhagen, Department of Biomedical Sciences, Copenhagen

  Registry updated 2026-11-02

• NCT07909889

  Semaglutide for Weight Management During Hormone Therapy for Early Breast Cancer

  Trial Treatment · Phase 2 · Aarhus University Hospital

  Department of Oncology, Aarhus University Hospital, Aarhus N

  Registry updated 2026-11-02

• NCT07301541

  Effectiveness of a 10-week Multicomponent Intervention Combined With Parent Education on Binge Eating Behavior in Children and Adolescents

  Trial Treatment · University of Aarhus

  Julemærkehjemmet Hobro, Hobro · Julemærkehjemmet Fjordmark, Kruså

  Registry updated 2026-10-30

• NCT07037459

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  Trial Treatment · Phase 3 · Amgen

  Aarhus Universitetshospital, Aarhus N · Esbjerg sygehus, Syddansk Universitetshospital, Esbjerg · Frederiksberg/Bispebjerg Hospitaler, Frederiksberg · Herlev and Gentofte Hospital, Herlev · Regionshospitalet Gødstrup, Herning · Hvidovre Hospital, Hvidovre · Sjaellands Universitetshospital, Roskilde, Roskilde

  Registry updated 2026-10-29

• NCT07872904

  FutureShape Family

  Trial Treatment · Phase 4 · Signe Torekov

  University of Copenhagen, Department of Biomedical Sciences, Copenhagen

  Registry updated 2026-10-29

• NCT07757087

  A research study to see how NNC0487-0111 affects the body’s energy use after a weight loss in adults living with obesity, compared to a low-calorie diet or placebo

  Trial Treatment · Phase 1 · Novo Nordisk A/S

  Region Midtjylland, Aarhus N

  Registry updated 2026-10-28

• NCT07900178

  Sustaining Health After an Intensive Weight-loss Pro-gramme

  Research · Copenhagen University Hospital, Hvidovre

  Copenhagen University Hospital, Hvidovre, dep. for Endocrinology, Copenhagen

  Registry updated 2026-10-28

• 2024-516654-22-00

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)

  Trial Treatment · Phase 3 · Amgen Inc.

  Esbjerg Og Grindsted Sygehus, Esbjerg · Region Hovedstaden, Frederiksberg · Region Hovedstaden, Herlev · Region Midtjylland, Herning · Region Hovedstaden, Hvidovre · Region Sjaelland, Roskilde

  Registry updated 2026-10-27

• NCT07481630

  AMAZE 5: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and knee osteoarthritis lose weight and reduce pain

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  Region Midtjylland, Aarhus N · Region Hovedstaden, Frederiksberg · Sanos A/S, Herlev

  Registry updated 2026-10-26

• NCT07893743

  Changes in Intestinal Permeability and Systemic Inflammation Following Fast Food Overfeeding.

  Trial Treatment · University Hospital, Gentofte, Copenhagen

  Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup

  Registry updated 2026-10-26

• NCT07571005

  AMAZE 3: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and obstructive sleep apnoea not treated with positive airway pressure lose weight and improve sleep apnoea

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  Region Midtjylland, Herning · Region Sjaelland, Koege

  Registry updated 2026-10-22

• NCT07567001

  HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  Region Syddanmark, Aabenraa · Rigshospitalet, Copenhagen Oe · Region Hovedstaden, Frederiksberg · Region Hovedstaden, Herlev · Regionshospital Nordjylland, Hjoerring · Holbaek Sygehus, Holbæk · Region Hovedstaden, Hvidovre · Odense University Hospital, Svendborg · Region Midtjylland, Viborg

  Registry updated 2026-10-21

• NCT07527195

  Understanding the effect of CagriSema, cagrilintide, and semaglutide on muscle health

  Trial Treatment · Phase 1 · Novo Nordisk A/S

  Region Midtjylland, Aarhus N

  Registry updated 2026-10-16

• NCT07861100

  A research study to look at how well zenagamtide works compared to placebo in people with established atherosclerotic cardiovascular disease and either overweight or obesity

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  Region Syddanmark, Aabenraa · Region Midtjylland, Aarhus N · Region Hovedstaden, Herlev · Region Midtjylland, Herning · Region Hovedstaden, Hvidovre · Lillebaelt Hospital, Kolding

  Registry updated 2026-10-15

• NCT07253285

  A research study on how well cagrilintide and CagriSema work in children and adolescents with excess body weight

  Trial Treatment · Phase 4 · Novo Nordisk A/S

  Holbaek Sygehus, Holbæk

  Registry updated 2026-10-06

• NCT07010432

  The Role of the Amylin Analogue Cagrilintide in Bone Metabolism

  Trial Treatment · Phase 1 · Novo Nordisk A/S

  Steno Diabetes Center Copenhagen, Herlev

  Registry updated 2026-10-05

• NCT07816744

  Danish Trial of Weight Loss to Reduce Atrial Fibrillation Progression

  Trial Treatment · Axel Brandes

  University Hospital Bispebjerg and Frederiksberg, Copenhagen · Esbjerg Hospital, University Hospital of Southern Denmark, Esbjerg

  Registry updated 2026-10-05

• NCT07776509

  A Study to evaluate effect of AZD6234 as an adjunct to incretin-based therapies in adult participants with obesity or overweight with weight-related comorbidity with or without Type 2 Diabetes Mellitus

  Trial Treatment · Phase 3 · AstraZeneca AB

  Region Midtjylland, Aarhus N · Sanos A/S, Gandrup · Steno Diabetes Center Copenhagen, Herlev · Sanos A/S, Herlev · Holbaek Sygehus, Holbæk · Hvidovre Hospital, Hvidovre · Faenosundlaegerne I/S, Middelfart · Region Syddanmark, Odense C · Sanos A/S, Vejle

  Registry updated 2026-09-28

• NCT06423599

  FIT-HF - Effect of weight loss on physical and cardiac performance in patients with heart failure and obesity

  Trial Treatment · Phase 2 · Region Hovedstaden

  Hvidovre Hospital, Hvidovre

  Registry updated 2026-09-03

• NCT06309238

  Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial

  Trial Treatment · Carsten Dirksen

  Steno Diabetes Center Aarhus, Aarhus Universitets Hospital, Aarhus · The Department of Medicine and Department of Surgery, University Hospital of South West Jutland, Esbjerg · The Department of Medicine and the Gastro Unit, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre · Department of Surgery, Viborg Regional Hospital, Viborg

  Registry updated 2026-08-21

• NCT07698132

  HALO-TRIAL: High, Medium And LOw Intensity Psychotherapy for Binge Eating Disorder

  Trial Treatment · Herlev and Gentofte Hospital

  Mental Health Centre Ballerup, Ballerup Municipality

  Registry updated 2026-07-13

• NCT07692646

  The Effect of Fasting on Peak Fat Oxidation, Mitochondrial Coupling and Extracellular Matrix

  Trial Treatment · University of Copenhagen

  Department of Biomedical Sciences, Copenhagen

  Registry updated 2026-07-09

All Obesity trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error